Preventative treatment, or follow-up therapy following a heart attack, must complement the glycoside effects, but not interfere with required allopathic drugs. In addition, the therapy should enable the patient to reduce the dosage of prescribed drugs over time. ADEL 54 (CANGUST) drops provide anti-inflammatory, anti-thrombotic properties that help prevent coronary insufficiency and sclerosis, but do not disrupt drug therapies. This remedy also prevents hyperacidification of the heart muscle, making it valuable for prophylaxis of a heart attack.